Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: curcumin

October 27, 2026 Drug delivery / Pharma applications / Uncategorized

Bio-inks for skin regeneration: phase-adaptive design, multifunctional platforms, and 4D bioprinting frontiers

Chronic wounds and scarring represent major clinical challenges owing to dysregulated tissue repair processes. The emergence of 3D bioprinting offers

Continue reading

September 9, 2026 Drug delivery / Pharma applications / Uncategorized

Enhancing Curcumin Efficacy Against Triple-Negative Breast Cancer

Researchers from Türkiye developed GE11-functionalized curcumin/carboxymethyl-β-cyclodextrin (Cur/CM-βCD) supramolecular assemblies, using GE11 as an EGFR-targeting peptide, to enhance the therapeutic potential

Continue reading

August 24, 2026 Cosmetics and toilettry / Drug delivery / Non-pharma applications / Pharma applications

Cyclodextrin-Based Delivery Systems in Cosmeceuticals

This article aims to provide a comprehensive, evidence-based overview of the current and potential roles of cyclodextrins as safe, effective,

Continue reading

June 18, 2026 Drug delivery / Food / Other industrial use

Pressurized hot water to improve complexation

This study introduces an integrated, green solubilization strategy by combining pressurized hot water (PHW) treatment with β-cyclodextrin (βCD) complexation to

Continue reading

January 7, 2026 Food / Non-pharma applications

CD-enabled active food packaging in the recent literature

The incorporation of inclusion complexes into films, hydrogels as pads is an effective approach for developing antimicrobial active packaging for

Continue reading

July 16, 2025 Drug delivery / Pharma applications

Encapsulation effects on the structure and tautomeric distribution of curcumin in the β-cyclodextrin cavity: an ion mobility study

Encapsulated 1 : 1 and 1 : 2 complexes of the bioactive compound curcumin in the β-cyclodextrin (βCD) cavity have been investigated by drift

Continue reading

November 19, 2024 Food / Non-pharma applications

Dietary Antioxidants and Natural Compounds in Preventing Thrombosis and Cardiovascular Disease

Reactive oxygen species (ROS) contribute to endothelial dysfunction, platelet activation, and coagulation abnormalities, promoting thrombus formation. Given the growing interest

Continue reading

August 14, 2024 Drug delivery / Pharma applications

Recent Advancements and Trends of Topical Drug Delivery Systems in Psoriasis: A Review and Bibliometric Analysis

Psoriasis is an immune-mediated inflammatory skin disease where topical therapy is crucial. While various dosage forms have enhanced the efficacy

Continue reading

July 15, 2024 Drug delivery / Pharma applications

Epichlorohydrin-crosslinked CD polymer for gastric delivery of curcumin

Although cross-linking with epichlorohydrin (EPC) is a process studied long time ago, however its use as a gastric solubility enhancer

Continue reading

March 25, 2024 Drug delivery / Food / Non-pharma applications / Pharma applications

Clinically Effective Molecules of Natural Origin for Obesity Prevention or Treatment

The prevalence and incidence of obesity and the comorbidities linked to it are increasing worldwide. Current therapies for obesity and

Continue reading

Posts pagination

1 2 3 Next Posts»

Recent Posts

  • Concluding 22nd International Cyclodextrin Symposium (ICS-22)
  • Enhancing Linezolid Solubilization with β-Cyclodextrin Polymer Fractions of Different Molecula Weight
  • Book chapter: Functionalized cyclodextrins in drug delivery
  • β-Cyclodextrin-Complexed 1,8-Cineole Attenuates Motor Deficits and Preserves Tyrosine Hydroxylase Immunoreactivity in a Reserpine-Induced Mouse Model of Parkinsonism
  • Disruption of endosomal transport in cyclodextrin-mediated cytotoxicity

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (28)
  • Analysis (75)
  • CD as API (361)
  • CD derivatives (443)
  • Cosmetics and toilettry (55)
  • Diagnosis (15)
  • Drug delivery (832)
  • E-ducation (64)
  • Environmental (144)
  • Events (243)
  • Food (239)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (46)
  • Non-pharma applications (428)
  • Other industrial use (114)
  • Pharma applications (1,241)
  • Supramolecular systems (45)
  • Uncategorized (176)

Top Posts

  • Enhancing Linezolid Solubilization with β-Cyclodextrin Polymer Fractions of Different Molecula Weight
  • Rafael Holdings Announced Submission of New Drug Application to FDA for Trappsol®Cyclo™ (remibetadex) for the Treatment of Niemann-Pick Disease Type C
  • Concluding 22nd International Cyclodextrin Symposium (ICS-22)
  • Cyclodextrin Produced In situ: Rethinking Oat Milk Design for Better Performance
  • Disruption of endosomal transport in cyclodextrin-mediated cytotoxicity
  • Practical Considerations about the Cyclodextrin Solubilities – A Quickstart Guide for Newbies
  • Arthur Lütringhaus, Godfather of catenanes was born 120 years ago
  • 16th Central European Symposium on Pharmaceutical Technology (CESPT 2027)
  • β-Cyclodextrin-Complexed 1,8-Cineole Attenuates Motor Deficits and Preserves Tyrosine Hydroxylase Immunoreactivity in a Reserpine-Induced Mouse Model of Parkinsonism
  • Enantioseparation and molecular docking study of selected chiral pharmaceuticals on a commercialized phenylcarbamate-β-cyclodextrin column using polar organic mode

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,470 other subscribers
Loading Comments...